SCHEMBL20596047

SCHEMBL20596047

N#Cc1c(-n2c3ccccc3c3ccccc32)c(-n2c3ccc(-c4ccccc4)cc3c3cc(-c4ccccc4-c4ccccc4)ccc32)c(-c2ccccc2)c(-n2c3ccc(-c4ccccc4)cc3c3cc(-c4ccccc4-c4ccccc4)ccc32)c1-n1c2ccccc2c2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE9A O76083 2/20 0.36
PDE1C Q14123 1/20 0.36
PARP1 P09874 1/20 0.36
HTR3A P46098 1/20 0.35
TSPO P30536 1/20 0.35
ALDH1A1 P00352 5/20 0.34
KDM4E B2RXH2 3/20 0.34
RXFP1 Q9HBX9 2/20 0.34
LMNA P02545 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
POLB P06746 1/20 0.34
HPGD P15428 2/20 0.33
GAA P10253 1/20 0.33
MAPK1 P28482 1/20 0.33
GRIA4 P48058 2/20 0.33
GRIA2 P42262 1/20 0.33
SQOR Q9Y6N5 1/20 0.33
GRM5 P41594 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20596556 0.98 PDE9A (0.37) PDE9APDE1CPARP1HTR3AALDH1A1
SCHEMBL22250955 0.94 PDE9A (0.39) PDE9APDE1CPARP1HTR3ATSPO
SCHEMBL20596032 0.94 PDE9A (0.39) PDE9APDE1CPARP1HTR3ATSPO
SCHEMBL21765780 0.94 PDE9A (0.39) PDE9APDE1CPARP1HTR3ATSPO
SCHEMBL20596020 0.94 PDE9A (0.39) PDE9APDE1CPARP1HTR3ATSPO
SCHEMBL22251505 0.94 PDE9A (0.39) PDE9APDE1CPARP1HTR3ATSPO
SCHEMBL20596627 0.94 PDE9A (0.39) PDE9APDE1CPARP1HTR3ATSPO
SCHEMBL20596603 0.94 PDE9A (0.39) PDE9APDE1CPARP1HTR3ATSPO
SCHEMBL23464423 0.91 PDE9A (0.38) PDE9APDE1CPARP1HTR3ATSPO
SCHEMBL21840874 0.91 PDE9A (0.38) PDE9APDE1CHTR3ATSPOALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11638390-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-04-25 US disclosed
US-11638390-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-04-25 US disclosed
US-20200119287-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-04-16 US disclosed
US-20200119287-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-04-16 US disclosed
WO-2018237389-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux Inc. (JP) 2018-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200119287-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, CLTB, CYBA PDE9A 4262/4885PDE1C 4873/4885PARP1 2950/4885
US-11638390-B2 Composition of matter for use in organic light-emitting diodes CRY2, CLTB, CYBA PDE9A 4262/4885PDE1C 4873/4885PARP1 2950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.